JPWO2019165156A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019165156A5
JPWO2019165156A5 JP2020543928A JP2020543928A JPWO2019165156A5 JP WO2019165156 A5 JPWO2019165156 A5 JP WO2019165156A5 JP 2020543928 A JP2020543928 A JP 2020543928A JP 2020543928 A JP2020543928 A JP 2020543928A JP WO2019165156 A5 JPWO2019165156 A5 JP WO2019165156A5
Authority
JP
Japan
Prior art keywords
seq
cells
domain
acid sequence
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020543928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021513857A (ja
JP7358369B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/019065 external-priority patent/WO2019165156A1/en
Publication of JP2021513857A publication Critical patent/JP2021513857A/ja
Publication of JPWO2019165156A5 publication Critical patent/JPWO2019165156A5/ja
Application granted granted Critical
Publication of JP7358369B2 publication Critical patent/JP7358369B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543928A 2018-02-23 2019-02-22 Ｃｄ８３結合キメラ抗原受容体 Active JP7358369B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862634435P 2018-02-23 2018-02-23
US62/634,435 2018-02-23
US201862677783P 2018-05-30 2018-05-30
US62/677,783 2018-05-30
PCT/US2019/019065 WO2019165156A1 (en) 2018-02-23 2019-02-22 Cd83-binding chimeric antigen receptors

Publications (3)

Publication Number Publication Date
JP2021513857A JP2021513857A (ja) 2021-06-03
JPWO2019165156A5 true JPWO2019165156A5 (ru) 2022-02-28
JP7358369B2 JP7358369B2 (ja) 2023-10-10

Family

ID=67686942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020543928A Active JP7358369B2 (ja) 2018-02-23 2019-02-22 Ｃｄ８３結合キメラ抗原受容体

Country Status (15)

Country Link
US (1) US20210032336A1 (ru)
EP (1) EP3755722A4 (ru)
JP (1) JP7358369B2 (ru)
KR (1) KR20200130324A (ru)
CN (1) CN112004832A (ru)
AU (1) AU2019226101A1 (ru)
BR (1) BR112020017015A2 (ru)
CA (1) CA3092220A1 (ru)
IL (1) IL276836A (ru)
MA (1) MA51917A (ru)
MX (1) MX2020008803A (ru)
PH (1) PH12020500632A1 (ru)
SG (1) SG11202007755YA (ru)
WO (1) WO2019165156A1 (ru)
ZA (1) ZA202005837B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114615992A (zh) * 2019-08-16 2022-06-10 H.李.莫菲特癌症中心和研究所股份有限公司 表达t调节性细胞的抗cd83嵌合抗原受体
CN114929341A (zh) * 2019-08-16 2022-08-19 H.李.莫菲特癌症中心和研究所股份有限公司 用于治疗髓系恶性肿瘤的嵌合抗原受体
US11802159B2 (en) * 2019-09-30 2023-10-31 The Trustees Of The University Of Pennsylvania Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)
WO2021127212A2 (en) * 2019-12-18 2021-06-24 H. Lee Moffitt Cancer Center And Research Institute Inc. Systems and methods for producing efficacious regulatory t cells
US20230390391A1 (en) * 2020-01-22 2023-12-07 Regents Of The University Of Minnesota Bi-specific chimeric antigen receptor t cells targeting cd83 and interleukin 6 receptor
US20230107770A1 (en) * 2020-02-20 2023-04-06 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of enhancing immunotherapy using er stress pathway inhibitors
US20230321239A1 (en) * 2020-08-14 2023-10-12 H. Lee Moffitt Cancer Center And Research Institute Inc. Chimeric antigen receptor t cells for treating autoimmunity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185040A1 (en) * 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
JP2013040160A (ja) * 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用
JP2013150592A (ja) 2011-07-01 2013-08-08 Genentech Inc 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用
CA2899960C (en) * 2013-02-01 2022-05-03 Transbio Ltd Anti-cd83 antibodies and use thereof
NZ731491A (en) 2014-10-23 2021-12-24 Kira Biotech Pty Ltd Cd83 binding proteins and uses thereof
AU2015338984A1 (en) * 2014-10-31 2017-04-27 The Trustees Of The University Of Pennsylvania Methods and compositions for modified T cells
AU2016274989A1 (en) 2015-06-12 2017-11-02 Immunomedics, Inc. Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
CA2990177A1 (en) * 2015-06-25 2016-12-29 Icell Gene Therapeutics Llc Chimeric antigen receptors (cars), compositions and methods thereof
US20200281973A1 (en) * 2016-03-04 2020-09-10 Novartis Ag Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore

Similar Documents

Publication Publication Date Title
JP2021087455A5 (ru)
JP2021177771A5 (ru)
JP2021094037A5 (ru)
JP2019527557A5 (ru)
JP2020517295A5 (ru)
CN109983033B (zh) 调节细胞表达的生物活性的结合分子
JP2020114264A5 (ru)
JP2022040287A5 (ru)
JP2020530289A5 (ru)
IL301527A (en) Methods for selective expansion of gamma delta T-cell populations and preparations thereof
JP2020513754A5 (ru)
CA3014067A1 (en) Modified cells for immunotherapy
JP2019513370A5 (ru)
JP2018525033A5 (ru)
JP2024023228A5 (ru)
US20210015870A1 (en) Bcma-car-t cells
JP2020512973A5 (ru)
EP4107187A1 (en) Tissue targeted immunotolerance with a cd39 effector
JP2023530083A (ja) Ｈｌａ－ｇ及び別の抗原に対して結合特異性を有する二重特異性免疫細胞エンゲージャー
JPWO2019165156A5 (ru)
WO2022105826A1 (zh) 靶向nkg2a的抗体及其用途
JPWO2020180591A5 (ru)
JPWO2020228825A5 (ru)
JPWO2021034689A5 (ru)
JPWO2021034684A5 (ru)